BPA Call VA261BP0052-VA26012J0018

This cost-per-test, lease, and contract for reagents and automated or semi-automated instrumentation for infectious disease immune response detection was awarded by the Defense Health Agency to Diasorin Inc. The firm fixed price delivery order, valued at $59,490.03, has a period of performance through September 30, 2023. To be performed at Madigan Army Medical Center in Washington, this contract supports the Defense Health Agency's mission to provide diagnostic testing for infectious diseases...

The Defense Health Agency awarded a purchase order to Diasorin Inc. valued at $363,378.46 for various reagents and controls with use of a Diasorin Liaison XL analyzer, effective August 1, 2023. Performance occurs at Stillwater, Minnesota. The base period runs August 1, 2023 through September 30, 2023, with ultimate completion scheduled for September 30, 2027. The procurement is firm-fixed-price with no set-aside designation. The originating opportunity, posted June 2, 2023, was a...

This is a federal contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of reagents, materials, and test supplies. The $15,370.43 firm-fixed-price contract has an ultimate completion date of October 15, 2024. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...

This is a firm-fixed-price contract awarded by the Defense Health Agency to Biomerieux Inc., through its Biomerieux, Inc. division, for the provision of controls, reagents, and consumables. The contract has a ceiling value of $35,000.00 and a period of performance ending on September 30, 2016. The contract is not designated as a set-aside. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in microbiological testing solutions for medical, food safety, and industrial...

This contract award was made by the Department of the Air Force Materiel Command Lifecycle Management Center to Diasorin Inc., a for-profit foreign-owned company that specializes in diagnostic testing equipment and assays. The $199,230.00 firm-fixed-price purchase order is for the provision of COVID-19 reagents. Diasorin has previously supported federal healthcare agencies such as the Department of Veterans Affairs (VA), Department of Defense (DoD), and Department of Health and Human Services...

This is a firm-fixed-price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery to Biomerieux Inc., a global leader in in vitro diagnostics. The $128,293.98 contract is for the delivery of COST PER TEST REAGENTS and does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...

This federal contract was awarded by the Department of the Army Medical Command to Bio Rad Laboratories Inc., a global manufacturer of life science research and clinical diagnostic products. The $109,585.93 firm-fixed-price purchase order is for the delivery of Syphilis Total & RPR Reagent Packs. The contract is not designated as a small business set-aside. Bio Rad Laboratories Inc. has a track record of providing a variety of laboratory equipment, reagents, and services to support federal...

The Defense Health Agency awarded a $2.353 million definitive contract to Abbott Laboratories Inc., through its Abbott Diagnostics Division, for chemistry and immunochemistry analyzers, reagents, and supplies on November 1, 2024, with no set-aside used. The originating solicitation, posted as market research by the U.S. Army Health Contracting Activity Medical Readiness Contracting Office-East, sought two analyzers with fully-automated testing capability, Hepatitis A and B testing within 30...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price delivery order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide reagents and consumables for the Abbott M2000SP and M2000RT diagnostic platforms. The $148,793.75 award falls under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits. This award does not utilize a set-aside designation. As a major manufacturer of medical devices and...

The Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order valued at $63,189.00 to Bio-Rad Laboratories, Inc. on August 26, 2024, for HIV diagnostic testing products and supplies. The contract deliverables include GS HIV-1/HIV-2 Plus O enzyme immunoassay kits, GEENIUS HIV 1/2 supplemental assay reagents for diagnostic testing, GEENIUS HIV 1/2 control materials (120 UI x 2), and GS HIV-1 Western blot test kits (40 tests), all intended for detection and...